TRGM

Targeted Medical Pharma, Inc. TRGM

TRGM
Targeted Medical Pharma, Inc. NLVVF
New Leaf Ventures Inc IAGX
Imagenetix, Inc. BZAMF
BZAM Ltd. SYVC
Synovics Pharmaceuticals, Inc. CVHIF
Ventura Cannabis & Wellness Corporation CMRA
Comera Life Sciences Holdings, Inc. QMDT
Quick-Med Technologies, Inc. SNNAQ
Sienna Biopharmaceuticals, Inc. GBIM
GlobeImmune, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode TRGM NLVVF IAGX BZAMF SYVC CVHIF CMRA QMDT SNNAQ GBIM
6M 0.00 % 0.00 % 0.00 % 900.00 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 % -80.00 %
YTD 0.00 % -97.84 % -50.00 % 900.00 % 0.00 % 0.00 % -50.00 % -50.00 % 0.00 % -50.00 %
1Y 0.00 % -96.77 % -50.00 % 9 900.00 % 0.00 % 0.00 % -50.00 % -50.00 % 0.00 % -50.00 %
3Y 0.00 % -99.91 % -96.67 % -99.98 % 0.00 % 900.00 % -99.99 % -80.00 % 0.00 % -85.71 %
5Y -99.40 % -99.96 % -96.67 % -100.00 % 0.00 % -96.00 % -100.00 % -99.29 % -98.44 % -99.97 %
10Y -99.00 % -99.98 % -99.90 % -100.00 % 0.00 % -99.99 % -100.00 % -99.15 % -100.00 % -100.00 %
Depuis le début -100.00 % -99.98 % -99.99 % -100.00 % 0.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 %

Dividende